Adeptus Health (ADPT) Tops Q2 EPS by 27c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $26.79 +3.84%
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: -23.8%
Financial Fact:
Net income (loss): -65.15M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Adeptus Health (NYSE: ADPT) reported Q2 EPS of $0.44, $0.27 better than the analyst estimate of $0.17. Revenue for the quarter came in at $104.5 million versus the consensus estimate of $85.52 million.
For earnings history and earnings-related data on Adeptus Health (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- TaskUs, Inc. (TASK) Tops Q3 EPS by 3c, Offers Guidance
- Paycom Software (PAYC) Tops Q3 EPS by 56c, Beats on Revenue; Offers FY26 Revenue Guidance
- Cytokinetics (CYTK) Tops Q3 EPS by 8c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
